Rankings
▼
Calendar
SCYX (SCYNEXIS, Inc.) Stock Financials & Earnings | Market Cap Arena
SCYX
SCYNEXIS, Inc.
Mkt Cap
$38M
Healthcare
·
Drug Manufacturers - Specialty & Generic
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$21M
Net Income (TTM)
-$9M
EPS (TTM)
-$0.14
Free Cash Flow (TTM)
-$5M
Gross Margin
9.5%
Op. Margin
-77.9%
Net Margin
-41.8%
FCF Margin
-25.6%
P/S Ratio (TTM)
1.9x
P/E Ratio (TTM)
—
YoY Rev Growth
+449.9%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Next: Q1 2026 · Mar 11
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$1M
$993K
-$11M
Q2 23
$131M
$131M
$117M
Q3 23
$2M
$1M
-$10M
Q4 23
$6M
-$9M
-$23M
Q1 24
$1M
$1M
-$10M
Q2 24
$736K
$736K
-$9M
Q3 24
$660K
$660K
-$10M
Q4 24
$977K
$977K
-$8M
Q1 25
$257K
$257K
-$9M
Q2 25
$1M
$1M
-$10M
Q3 25
$334K
$334K
-$8M
Q4 25
$19M
$0
$11M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
6.9x
—
Q2 23
0.3x
0.9x
Q3 23
0.3x
0.5x
Q4 23
0.3x
0.6x
Q1 24
0.3x
0.4x
Q2 24
3.9x
—
Q3 24
4.5x
—
Q4 24
10.2x
—
Q1 25
14.5x
—
Q2 25
11.7x
—
Q3 25
13.0x
—
Q4 25
1.9x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$19M
-$19M
Q2 23
$74M
$74M
Q3 23
$12M
$12M
Q4 23
-$8M
-$8M
Q1 24
-$4M
$0
Q2 24
-$11M
-$11M
Q3 24
$765K
$765K
Q4 24
-$10M
-$10M
Q1 25
-$7M
-$7M
Q2 25
-$7M
-$7M
Q3 25
-$9M
-$9M
Q4 25
$18M
$18M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$0
Q1 24
$4M
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$0
Q3 25
$0
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+64.5%
-42.2%
Q2 23
+9836.1%
-35.2%
Q3 23
+13.1%
-49.2%
Q4 23
+280.4%
+20.2%
Q1 24
+21.5%
-7.9%
Q2 24
-99.4%
-33.2%
Q3 24
-62.5%
-7.4%
Q4 24
-83.1%
-68.7%
Q1 25
-81.3%
-18.5%
Q2 25
+85.3%
+9.5%
Q3 25
-49.4%
-20.4%
Q4 25
+1808.5%
-10.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$707K
62.6%
Q2 23
$728K
0.6%
Q3 23
$632K
35.9%
Q4 23
$557K
9.6%
Q1 24
$705K
51.3%
Q2 24
$759K
103.1%
Q3 24
$901K
136.5%
Q4 24
$981K
100.4%
Q1 25
$819K
318.7%
Q2 25
$820K
60.1%
Q3 25
$526K
157.5%
Q4 25
$687K
3.7%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$7M
$5M
Q2 23
$7M
$7M
Q3 23
$6M
$5M
Q4 23
$11M
$3M
Q1 24
$7M
$4M
Q2 24
$7M
$3M
Q3 24
$8M
$3M
Q4 24
$4M
$5M
Q1 25
$5M
$4M
Q2 25
$7M
$4M
Q3 25
$5M
$3M
Q4 25
$5M
$4M
marketcaparena.com
Revenue Segments
License and Service
Product
Quarter
License and Service
Product
Q2 23
$131M
$468K
Q3 23
$2M
-$614K
Q1 24
$1M
—
Q2 24
$736K
—
Q3 24
$660K
—
Q1 25
$257K
—
Q2 25
$1M
—
Q3 25
$334K
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$27M
$28M
$55M
Q2 23
$58M
$28M
$86M
Q3 23
$44M
$44M
$88M
Q4 23
$34M
$40M
$74M
Q1 24
$36M
$45M
$81M
Q2 24
$26M
$47M
$73M
Q3 24
$29M
$40M
$69M
Q4 24
$16M
$43M
$59M
Q1 25
$7M
$34M
$41M
Q2 25
$11M
$34M
$45M
Q3 25
$15M
$23M
$38M
Q4 25
$21M
$19M
$40M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
48M
+46.1%
Q2 23
50M
+4.5%
Q3 23
48M
-4.1%
Q4 23
48M
+0.1%
Q1 24
49M
+1.3%
Q2 24
49M
-0.1%
Q3 24
49M
+0.2%
Q4 24
38M
-21.9%
Q1 25
49M
+30.2%
Q2 25
50M
+0.6%
Q3 25
50M
+0.3%
Q4 25
44M
-12.7%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$14K
87
FY 15
$23K
11
FY 16
$18K
14
FY 17
$14K
19
FY 18
$11K
24
FY 19
$4K
27
FY 20
$0
38
FY 21
$235K
56
FY 22
$141K
36
FY 23
$5M
29
FY 24
$134K
28
FY 25
$1M
18
marketcaparena.com